Giulia Odorici

21PUBLICATIONS
69CO-AUTHORS
Gene and molecular therapyImmunogenetics (incl. genetic immunology)Humoural immunology and immunochemistryMetabolic medicineAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 29, 2025
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study.

Riccardo Balestri, Giulia Odorici, Michela Magnano

|Dec 07, 2023
PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy.

L Sacchelli, F Filippi, A Balato

|Dec 21, 2021
Efficacy and safety of guselkumab in two psoriatic patients with hepatitis B and C virus infection.

Francesco Messina, Francesca Peccerillo, Giulia Odorici

|Aug 10, 2021
Efficacy assessment of a TCA/H2O2 compositum for skin ageing treatment by confocal laser microscopy and optical coherence tomography.

F Peccerillo, G Odorici, S Ciardo

|May 19, 2021
Integrated metabolomic analysis and cytokine profiling define clusters of immuno-metabolic correlation in new-onset psoriasis.

Elisabetta Tarentini, Giulia Odorici, Valeria Righi

|May 11, 2021
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis.

Stefano Piaserico, Andrea Conti, Francesco Messina

Pageof 4